
|Articles|December 4, 2015
New Biosimilar Under Review in Top Specialty Pharmacy News
Author(s)Davy James, Managing Editor
Catch up with any news you missed this week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/new-biosimilar-under-review-in-top-specialty-pharm" target="_blank">View the story "New Biosimilar Under Review in Top Specialty Pharmacy News" on Storify</a>]
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
2
New CKD Outcome Set Tells Pharmacists What to Measure
3
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
4
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
5



































































































